Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
vaccine plant
Manufacturing
Its future murky, CSL Seqirus opens $1B vax plant in Australia
CSL Seqirus has opened the doors to a new $1 billion cell-based influenza vaccine and antivenom facility in Melbourne.
Joseph Keenan
Dec 9, 2025 9:08am
MilliporeSigma debuts new plant as part of €440M investment
Sep 18, 2025 8:30am
Merck, Sanofi, Fujifilm and more—Fierce Pharma Asia
Apr 22, 2022 8:42am
Sanofi, BeiGene-Novartis, remdesivir and more—Fierce Pharma Asia
Apr 16, 2021 5:02am
GSK starts $175M plant to boost production of vax star Bexsero
Mar 22, 2017 12:03pm
FiercePharmaAsia: GSK, Opdivo, Takeda, Sun Pharma and more
Dec 1, 2016 4:07pm
